PLEASANTON, CA--(Marketwired - Mar 21, 2014) - ZELTIQ Aesthetics, Inc. (
"The introduction of the CoolSmooth applicator underscores the company's commitment to optimizing patient outcomes and expanding CoolSculpting treatment areas," said Mark Foley, President and Chief Executive Officer of ZELTIQ. "The ability for the CoolSculpting procedure to treat non-pinchable fat will bring new patients to -- as well as current patients back into -- the practice."
"As a long-time user of the CoolSculpting system, I have personally seen the reproducible, consistent results and high patient satisfaction it can deliver. With the CoolSmooth applicator, I can now confidently treat non-pinchable fat bulges knowing that it can reliably deliver the same results and satisfaction associated with the CoolSculpting procedure," said Suzanne L. Kilmer, MD, director of the Laser and Skin Surgery Center of Northern California in Sacramento, Calif.
In the United States, the CoolSculpting procedure is cleared for non-invasive fat reduction in the abdomen and flank. In other international markets, it is cleared for general non-invasive fat reduction. The CoolSculpting treatment results in a noticeable reduction of fat in the treated areas, and the treated fat is gone for good. Most patients can start to see results as soon as 3 weeks following treatment, with the most dramatic results occurring over a period of 1-3 months. Every patient is unique, which is why ZELTIQ recommends a customized treatment plan as part of the initial consultation. Additional treatments in the same or multiple areas may enhance the desired aesthetic effect.
For more information about the CoolSmooth applicator and the CoolSculpting procedure, visit ZELTIQ at AAD Booth #4104.
About the CoolSculpting®Procedure
The CoolSculpting procedure is a non-surgical, clinically proven procedure that selectively reduces fat bulges in problem areas using a patented cooling technology. Cleared by the FDA for noninvasive fat reduction in the abdomen and flank, it gently cools unwanted fat cells in the body to induce a natural, controlled elimination of fat cell without harming surrounding tissue, and the treated fat cells are gone for good. Over 1,000,000 CoolSculpting cycles and 2,200 systems have been shipped to more than 60 countries. The CoolSculpting procedure is available through an elite network of CoolSculpting Centers worldwide. Dermatologists, plastic surgeons and leading aesthetic specialists that offer CoolSculpting can be found at www.coolsculpting.com.
About ZELTIQ® Aesthetics, Inc.
ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting system, is designed to selectively reduce stubborn fat that may not respond to diet or exercise. The CoolSculpting procedure is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed the CoolSculpting procedure to safely, noticeably, and measurably reduce the fat layer.
- Health Care Industry